Sean L Edelstein1, Jennifer DeMatteo, Christopher G Stoeger, Marian S Macsai, Chi-Hsiung Wang. 1. *Department of Ophthalmology, Saint Louis University School of Medicine, Saint Louis, MO; †Eye Bank Association of America, Washington, DC; ‡Lions VisionGift, Portland, OR; §Division of Ophthalmologyl; and ¶Center for Biomedical Research Informatics, NorthShore University HealthSystem, Division of Ophthalmology, Evanston, IL.
Abstract
PURPOSE: To investigate the incidence of adverse reactions after corneal transplantation, reported to the Eye Bank Association of America. METHODS: Incidence of adverse reactions from January 1, 2007, to December 31, 2014, was analyzed. RESULTS: Of the 354,930 transplants performed in the United States, adverse reactions were reported in 494 cases (0.139%). Primary graft failure (PGF) predominated (n = 319; 0.09%) followed by endophthalmitis (n = 99; 0.028%) and keratitis (n = 66; 0.019%). The procedure type predominantly associated with PGF was endothelial keratoplasty (EK) in 56% (n = 180; 11 per 10,000 grafts), followed by penetrating keratoplasty (PK) in 42% (n = 135; 6.9 per 10,000 grafts). The procedure type predominantly associated with endophthalmitis and keratitis was EK in 63% (n = 104; 6.3 per 10,000 grafts) followed by PK in 34% (n = 56; 2.8 per 10,000 grafts), anterior lamellar keratoplasty in 1% (n = 2; 2.7 per 10,000 grafts), and keratoprosthesis in 1% (n = 2; 12.4 per 10,000 grafts). Although the incidence of PGF and endophthalmitis between PK and EK was noteworthy, the difference was not statistically significant (P = 0.098). Endophthalmitis-associated pathogens were isolated in 78% of cases: predominantly Candida species (65%), gram-positive organisms (33%), and gram-negative rods (2%). Keratitis-associated pathogens were isolated in 64% of cases: predominantly Candida species (81%), Herpes simplex virus (7%), gram-negative organisms (7%), and gram-positive organisms (5%). CONCLUSIONS: PGF was the most commonly reported adverse reaction, disproportionately associated with EK. An increasingtrend in the rate of endophthalmitis and keratitis was observed, disproportionately associated with EK and Candida species.
PURPOSE: To investigate the incidence of adverse reactions after corneal transplantation, reported to the Eye Bank Association of America. METHODS: Incidence of adverse reactions from January 1, 2007, to December 31, 2014, was analyzed. RESULTS: Of the 354,930 transplants performed in the United States, adverse reactions were reported in 494 cases (0.139%). Primary graft failure (PGF) predominated (n = 319; 0.09%) followed by endophthalmitis (n = 99; 0.028%) and keratitis (n = 66; 0.019%). The procedure type predominantly associated with PGF was endothelial keratoplasty (EK) in 56% (n = 180; 11 per 10,000 grafts), followed by penetrating keratoplasty (PK) in 42% (n = 135; 6.9 per 10,000 grafts). The procedure type predominantly associated with endophthalmitis and keratitis was EK in 63% (n = 104; 6.3 per 10,000 grafts) followed by PK in 34% (n = 56; 2.8 per 10,000 grafts), anterior lamellar keratoplasty in 1% (n = 2; 2.7 per 10,000 grafts), and keratoprosthesis in 1% (n = 2; 12.4 per 10,000 grafts). Although the incidence of PGF and endophthalmitis between PK and EK was noteworthy, the difference was not statistically significant (P = 0.098). Endophthalmitis-associated pathogens were isolated in 78% of cases: predominantly Candida species (65%), gram-positive organisms (33%), and gram-negative rods (2%). Keratitis-associated pathogens were isolated in 64% of cases: predominantly Candida species (81%), Herpes simplex virus (7%), gram-negative organisms (7%), and gram-positive organisms (5%). CONCLUSIONS:PGF was the most commonly reported adverse reaction, disproportionately associated with EK. An increasingtrend in the rate of endophthalmitis and keratitis was observed, disproportionately associated with EK and Candida species.
Authors: J Michael Miller; Matthew J Binnicker; Sheldon Campbell; Karen C Carroll; Kimberle C Chapin; Peter H Gilligan; Mark D Gonzalez; Robert C Jerris; Sue C Kehl; Robin Patel; Bobbi S Pritt; Sandra S Richter; Barbara Robinson-Dunn; Joseph D Schwartzman; James W Snyder; Sam Telford; Elitza S Theel; Richard B Thomson; Melvin P Weinstein; Joseph D Yao Journal: Clin Infect Dis Date: 2018-08-31 Impact factor: 9.079
Authors: Shahzad I Mian; Anthony J Aldave; Elmer Y Tu; Brandon D Ayres; Bennie H Jeng; Marian S Macsai; Michael L Nordlund; Jeffrey G Penta; Sudeep Pramanik; Loretta B Szczotka-Flynn; Allison R Ayala; Wendi Liang; Maureen G Maguire; Jonathan H Lass Journal: Cornea Date: 2018-09 Impact factor: 2.651
Authors: Rawan Saleh Alshabeeb; Ahmed Abdullah Aldayel; Hernan Martinez-Osorio; Muhammad Ali Ahad Journal: Int Ophthalmol Date: 2020-11-17 Impact factor: 2.031
Authors: Kimberly M Brothers; Robert M Q Shanks; Susan Hurlbert; Regis P Kowalski; Elmer Y Tu Journal: JAMA Ophthalmol Date: 2017-11-01 Impact factor: 7.389
Authors: Anna Song; Rashmi Deshmukh; Haotian Lin; Marcus Ang; Jodhbir S Mehta; James Chodosh; Dalia G Said; Harminder S Dua; Darren S J Ting Journal: Front Med (Lausanne) Date: 2021-07-07
Authors: Michael J Fliotsos; Jack A Campbell; Ximin Li; Marie B Engstrom; Christopher G Stoeger; Cathy McClory; Michael S Titus; Patrick Johnson; Kara B Johnston; Tim Fischer; Lisa K Brooks; Monty M Montoya; David B Glasser; Esen Karamursel Akpek; Divya Srikumaran Journal: Cornea Date: 2021-08-05 Impact factor: 3.152
Authors: Kimberly D Tran; Nicolas A Yannuzzi; Nancy Si; Nimesh A Patel; Darlene Miller; Guillermo Amescua; Audina M Berrocal; Harry W Flynn Journal: Am J Ophthalmol Case Rep Date: 2018-01-04